181 studies found for:
Leiomyoma: Clinical Trials
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Enrolling by invitation |
Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma
|
||||
| 2 | Terminated |
Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study
|
||||
| 3 |
Completed
Has Results |
Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids
|
||||
| 4 | Recruiting |
Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids
|
||||
| 5 | Recruiting |
China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids
|
||||
| 6 |
Completed
Has Results |
Two Year Extension Study of the Selective Progesterone Receptor Modulator Proellex® (CDB-4124) in Pre-Menopausal Women With Symptomatic Leiomyomata Who Have Previously Completed Study ZPU 003
|
||||
| 7 | Completed |
Fibroid Growth Study
|
||||
| 8 | Not yet recruiting |
Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin
|
||||
| 9 | Completed |
Safety Study of ExAblate for the Treatment of Uterine Fibroids
|
||||
| 10 | Withdrawn |
Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
|
||||
| 11 |
Completed
Has Results |
Therapeutic Magnetic Resonance Imaging (MRI)-Guided High Intensity Focused Ultrasound (HIFU) Ablation of Uterine Fibroids
|
||||
| 12 | Completed |
Therapeutic MRI-HIFU Ablation of Uterine Fibroids in a 3T MRI Scanner
|
||||
| 13 | Recruiting |
Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin
|
||||
| 14 | Completed |
Risk Factors for Uterine Fibroids: A Case Control Study
|
||||
| 15 | Completed |
Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
|
||||
| 16 | Terminated |
A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas
|
||||
| 17 | Completed |
A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.
|
||||
| 18 | Withdrawn |
To Evaluating the Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms in Premenopausal Women
|
||||
| 19 | Completed |
Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent
|
||||
| 20 | Terminated |
Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids
|
† Indicates status has not been verified in more than two years
